Kevin Shee, MD, PhD

Urology resident @UCSFUrology, Cancer Biologist, Dancer/Artist. Alumni @Harvard BA '11 @Dartmouth PhD ‘18 @GeiselMed MD ‘20

[Kevin Shee, MD, PhD @KShee11]

It’s been an honor and privilege to welcome @DanLinMD, Professor and Chair at @uwurology, as the Emil Tanagho Visiting Professor at @UCSFUrology. Thank you for all of the wonderful insights about all things PCa and surveillance, and for spending the afternoon with the residents!

[Kevin Shee, MD, PhD @KShee11]

@StanfordUrology @liaojoe1 @StanfordMed @AmerUrological Very big congratulations!

[Brian F. Chapin @ChapinMD]

The Future Urologic Oncologists program, @UroOnc will take place, July 24-26 in Indianapolis.

PGY2/3s, learn from the exec board + members what the SUO provides; fellowship, community, leadership opportunities + friendships.

Sign up soon. App deadline is approaching.

[Kevin Shee, MD, PhD @KShee11]

@Adam_Weiner535 @UrologyTimes @TheLancet We’ve been saying something similar for some time too! https://t.co/qC2yxKfn30

[COMPASS Research Group · UCL 🧭 @COMPASSurology]

🚨 JUST PUBLISHED in @EUplatinum

Updated meta-analysis (40 studies, 9,400+ patients) shows #bpMRI is NONINFERIOR to #mpMRI for clinically significant #PCa

🌟 First to include #PRIME trial data; proud to be part of this 🌏 collaboration

📄 Read HERE: https://t.co/QnuFBzKtsw

[Kevin Shee, MD, PhD @KShee11]

@drboss_urology @UCSFUrology @pcarroll_ @SamWashUro @UCSF Pleasure meeting you! Hope to meet again soon in the future.

[UroToday.com @urotoday]

Integrating genomic prognostic and hallmark signatures from #Decipher GRID to predict adverse outcomes in men on active surveillance for #ProstateCancer. Presented by @KShee11 @UCSFUrology. #GU26 written coverage by @chavarriagaj @PSH_Urology > https://t.co/LFzqN4yqRC @ASCO

[Matt Cooperberg @dr_coops]

Another terrific one from @KShee11: GG2 is highly heterogeneous and many of these cases can continue to be followed safely with #activesurveillance. Caution re: high PSAD and PI-RADS 5. And definitely consider unfavorable histology differently. #GU26 @ucsfurology

[Matt Cooperberg @dr_coops]

The inimitable @KShee11 @ucsfurology with one of his multiple high-impact #GU26 posters: Decipher GRID analysis of predictors of degeneration to unfavorable histology in #prostatecancer #activesurveillance

[Adam B. Weiner, MD @Adam_Weiner535]

🧬 Active surveillance (AS) ≠ one-size-fits-all for #ProstateCancer

🚨 New @EurUrolOncol data on Genomic Classifier (GC) in AS:

🔺High GC (≥0.6) → ↑ risk of major upgrading (GG≥3)
🔬↑ risk of unfavorable histology (IDC / cribriform)
🎯👀 Signals who may need closer surveillance, not overtreatment

🧠Risk-adapted AS matters

🔗https://t.co/ys2QaELgO8

@dr_coops @KShee11 @Decipher_VCYT @Davicioni @PCFnews @UrologyTimes @renalandurology @MRoupret

[Kevin Shee, MD, PhD @KShee11]

Also, a mentorship lineage that includes many giants and rising stars in the @UroOnc community! His impact has and will continue to transform prostate cancer management in the future. So fortunate to have @pcarroll_ as a mentor and to be a part of @UCSFUrology. #SUO2025

[Carissa Chu @CChuMD]

Standing ovation for @pcarroll_ recipient of this year’s Huggins medal #SUO2025. Astounding vision, intellect, and impact on the field and our patients. Congratulations.

#SUO2025 @UCSFUrology @UCSFCancer

[Kevin Shee, MD, PhD @KShee11]

@montypal @alexzhuDO @cityofhopeoc @PGrivasMDPhD @DanLinMD Congrats Alex! Very well-deserved!

[UroToday.com @urotoday]

Integrating genomic prognostic and hallmark signatures from Decipher GRID to predict adverse outcomes in men on active surveillance for #ProstateCancer. Presented by @KShee11 @UCSFUrology. #WSAUA25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/Xl7FtoAqYh @auawest

[Kevin Shee, MD, PhD @KShee11]

@Adam_Weiner535 @JAMA_current Thanks for sharing this Adam. Beautiful essay

[Kevin Shee, MD, PhD @KShee11]

@MMSiddiquiMD @MarylandUrology @UMmedschool @UMMC Congrats!!!

[UCSF Health @UCSFHospitals]

This year's @AmerUrological annual meeting featured many of our @UCSFUrology experts, including @ben_breyer, @drcoops, @SamWashUro, @KShee11, @SimaPorten, @haognguyen & @mvankuikenmd. Learn more about their leading-edge research: https://t.co/fGtG6jWM0i #AUA2025

[UCSFUrology @UCSFUrology]

Dr. Cooperberg receives ASPI’s 2025 Special Award for Patient Advocacy for leading a successful campaign to restore Active Surveillance in prostate cancer guidelines. https://t.co/r2L72l7Y0P

Check out @dr_coops presentation on AS:
https://t.co/i8VuWD2WMS

[UCSFUrology @UCSFUrology]

Congratulations to Dr. Porten on her appointment as Chief of Urologic Oncology! A role that recognizes her exceptional clinical expertise, research leadership, and long-standing commitment to advancing care for patients with genitourinary cancer.
https://t.co/U7nhByw66j

[Lindsay Hampson @lindsayahampson]

Excited for the next crop of urology hopefuls!!

We are an academically-focused program that will provide strong surgical skills, research and leadership opportunities, a chance to work with all specialties and diverse hospital systems, and above all a family to become a part of!

[Kevin Shee, MD, PhD @KShee11]

So thrilled to stay in the Bay to continue the research momentum I’ve built. Thanks to @pcarroll_ @SimaPorten @Uro_Max @haognguyen @dr_coops @SamWashUro @anobelodisho @CChuMD @MeeraChappidi for the support!

[UCSFUrology @UCSFUrology]

Congrats to Kevin Shee for matching into the UCSF UroOnc SUO fellowship program! @KShee11
#UroOnc #SUO #SUOMatch